APA-viite

Young, C. S., Clarke, K. M., Kettyle, L. M., Thompson, A., & Mills, K. I. (2017). Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy. Oncotarget.

Chicago-tyylinen lähdeviittaus

Young, Christine S., Kathryn M. Clarke, Laura M. Kettyle, Alexander Thompson, ja Ken I. Mills. "Decitabine-Vorinostat Combination Treatment in Acute Myeloid Leukemia Activates Pathways With Potential for Novel Triple Therapy." Oncotarget 2017.

MLA-viite

Young, Christine S., et al. "Decitabine-Vorinostat Combination Treatment in Acute Myeloid Leukemia Activates Pathways With Potential for Novel Triple Therapy." Oncotarget 2017.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.